The cMet complex may cooperate with other signalling complexes—that is, epidermal growth factor receptor, insulin-like growth factor receptor, and neurotrophin receptor complex—in regulation of gene expression and cancer cell behaviours, including cell motility 15–17. Here, MET is linked to cancer.